Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) Sees Significant Growth in Short Interest

Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (OTCMKTS:SFOSF) was the target of a significant increase in short interest in January. As of January 15th, there was short interest totaling 983,500 shares, an increase of 226.6% from the December 31st total of 301,151 shares. Based on an average daily volume of 1,580 shares, the short-interest ratio is presently 622.5 days. Based on an average daily volume of 1,580 shares, the short-interest ratio is presently 622.5 days.

Shanghai Fosun Pharmaceutical (Group) Stock Performance

Shares of SFOSF stock opened at $2.86 on Wednesday. Shanghai Fosun Pharmaceutical has a 12 month low of $1.62 and a 12 month high of $3.50. The stock has a 50-day moving average price of $3.00 and a 200 day moving average price of $2.92.

Shanghai Fosun Pharmaceutical (Group) Company Profile

Shanghai Fosun Pharmaceutical (Group) Co, Ltd. is a China‐based healthcare company and a core subsidiary of Fosun International. The company operates across drug manufacturing, distribution and retail services, and health management. Its product portfolio includes generic and proprietary small‐molecule drugs, bio‐pharmaceuticals, vaccines and traditional Chinese patent medicines. Through integrated R&D capabilities and strategic partnerships, Fosun Pharmaceutical pursues innovation across therapeutic areas such as oncology, cardiovascular, metabolic and infectious diseases.

The pharmaceutical manufacturing segment encompasses chemical pharmaceuticals, Chinese patent medicines and biological products, while the distribution arm manages one of the largest drug distribution networks in China, supplying hospitals, clinics and retail pharmacies.